NewsWeight loss drug maker sinks 25% after new safety data spooks investors Posted on June 8, 2026 by budd87309@gmail.com While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects. budd87309@gmail.com Airline profits set to halve this year as fuel costs jump by $100 billion: IATA Trump tells Iran and Israel to stop ‘shooting’ after they exchange strikes
